Zobrazeno 1 - 10
of 225
pro vyhledávání: '"N. Wahlgren"'
Autor:
Wai M. Yu, Azmil H. Abdul-Rahim, Alan C. Cameron, Janika Kõrv, Petr Sevcik, Danilo Toni, Kennedy R. Lees, N. Wahlgren, N. Ahmed, V. Caso, C. Roffe, A. Kobayashi, G. Tsivgoulis, D. Toni, G.A. Ford, K.R. Lees, P. Ringleb
Publikováno v:
Stroke. 51:2705-2714
Background and purpose: Early neurological deterioration (END) after stroke onset may predict severe outcomes. Estimated rates of END after intravenous thrombolysis among small patient samples have been reported up to 29.8%. We studied the incidence
Autor:
Anna Peeters, Niaz Ahmed, G. Vanhooren, Paolo Frigio Nichelli, B Keselman, Charith Cooray, Michael V. Mazya, Domenico Consoli, D Sanak, N Wahlgren, P Bassi, Andrea Zini
Publikováno v:
European journal of neurology, Vol. 26, no.8, p. 1091-1097 (2019)
Background and purpose: Patients with stroke mimics (SM), i.e. conditions with stroke-like symptoms, may risk harm if treated with intravenous thrombolysis (IVT). Current guidelines state low risk of intracerebral hemorrhage based on studies comprisi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef268cf7c612160d6001c094f221569e
https://hdl.handle.net/2078.1/239266
https://hdl.handle.net/2078.1/239266
Autor:
N. M. Bornstein, Erich Bluhmki, Werner Hacke, Philip M.W. Bath, P. Lyden, Jennifer Diedler, Stephen M. Davis, G Donnan, K. W. Muir, N Wahlgren, Ralph L. Sacco, C. Weimar, Barbara A. Gregson, Marek Sykora, H. C. Diener, Marc Hommel, Steven Warach, John R. Marler, M.G. Hennerici, P. Teal, K.R. Lees, Marc Fisher, L. Claesson, A Alexandrov, Markku Kaste, J Grotta, A. Shuaib, Myron D. Ginsberg, Pavel Siarnik
Publikováno v:
Stroke. 46:1269-1274
Background and Purpose— Increased sympathetic drive after stroke is involved in the pathophysiology of several complications including poststroke immunudepression. β-Blocker (BB) therapy has been suggested to have neuroprotective properties and to
Autor:
Marc Fisher, Joseph P. Broderick, Erich Bluhmki, Ralph L. Sacco, N Wahlgren, C. Weimar, Stephen M. Davis, Azmil H. Abdul-Rahim, James C. Grotta, Marc Hommel, N. M. Bornstein, Steven Warach, H. C. Diener, Andrei V. Alexandrov, J. Curram, Pooja Khatri, A. Shuaib, L. Claesson, John R. Marler, Myron D. Ginsberg, Heidi Sucharew, Geoffrey A. Donnan, Philip M.W. Bath, Rachael L. Fulton, K. W. Muir, Markku Kaste, P. Lyden, Werner Hacke, M.G. Hennerici, P. Teal, Dawn Kleindorfer, Kennedy R. Lees, Barbara A. Gregson
Publikováno v:
Stroke. 46:395-400
Background and Purpose— National Institutes of Health Stroke Scale (NIHSS) item profiles that were recently proposed may prove useful both clinically and for research studies. We aimed to validate the NIHSS item profiles in an acute cohort. Methods
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Should data monitoring committees assess efficacy when considering safety in trials in acute stroke?
Publikováno v:
International Journal of Clinical Practice. 61:1749-1755
The primary role of a trials Data Monitoring Committee (DMC) is to ensure the safety of enrolled patients. In stroke trials, safety is monitored typically by comparing death and stroke specific events between treatment groups. DMCs may also have the
Autor:
Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M, Gdovinova Z, Švigelj V, Csiba L, Fekete K, Kõrv J, Demarin, Vida, Bašic- Kes, Vanja, Vilionskis A, Jatuzis D, Krespi Y, Shamalov N, Andonova S, Ahmed N, Wahlgren N
BACKGROUND AND PURPOSE: According to the European license, alteplase can be given no sooner than 3 months after previous stroke. However, it is not known whether past history of stroke influences the effect of treatment. Our aim was to evaluate safet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::738affc259d17285398f863626289c3f
https://www.bib.irb.hr/810253
https://www.bib.irb.hr/810253
Googling Stroke ASPECTS to Determine Disability: Exploratory Analysis from VISTA-Acute Collaboration
Autor:
Philip M.W. Bath, P. Lyden, Marc Hommel, Richard Beare, Jian Chen, Ralph L. Sacco, Barbara A. Gregson, Steven Warach, Marc Fisher, L. Claesson, K. W. Muir, James C. Grotta, Markku Kaste, M.G. Hennerici, N Wahlgren, Andrei V. Alexandrov, Erich Bluhmki, Werner Hacke, C. Weimar, P. Teal, A. Shuaib, Myron D. Ginsberg, Stephen M. Davis, Thanh G. Phan, Kennedy R. Lees, Myzoon Ali, John R. Marler, Geoffrey A. Donnan, H. C. Diener, N. M. Bornstein
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0125687 (2015)
PLoS ONE
PLoS ONE
The summed Alberta Stroke Program Early CT Score (ASPECTS) is useful for predicting stroke outcome. The anatomical information in the CT template is rarely used for this purpose because traditional regression methods are not adept at handling colline
Autor:
Karlinski M, Kobayashi A, Czlonkowska A, Mikulik R, Vaclavik D, Brozman M, Svigelj V, Csiba L, Fekete K, Kõrv J, Demarin, Vida, Vilionskis A, Jatuzis D, Krespi Y, Ahmed N, Wahlgren N
BACKGROUND AND PURPOSE: Little is known about the effect of thrombolysis in patients with preexisting disability. Our aim was to evaluate the impact of different levels of prestroke disability on patients' profile and outcome after intravenous thromb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::82bcc0f6195f88759409657ec503325c
https://www.bib.irb.hr/810267
https://www.bib.irb.hr/810267
Autor:
N K, Mishra, N, Ahmed, A, Davalos, H K, Iversen, T, Melo, L, Soinne, N, Wahlgren, K R, Lees, A, Alexandrov
Publikováno v:
Neurology. 78(11)
Patients with concomitant diabetes mellitus (DM) and prior stroke (PS) were excluded from European approval of alteplase in stroke. We examined the influence of DM and PS on the outcomes of patients who received thrombolytic therapy (T; data from Saf